Here are six updates on gastroenterology companies from the past few weeks:
Enterome entered into an agreement with Takeda Pharmaceutical to cover Enterome's lead investigational drug candidate EB8018 for patients with Crohn's disease.
Japan's Fair Trade Commission approved Takeda's $62 billion acquisition of Shire, inching the drugmaker closer to complete regulatory approval.
The Drummond Group awarded Modernizing Medicine's EMA and EMA Mobile EHR systems Office of the National Coordinator for Health Information Technology 2015 Edition Health IT Module Certification.
Pentax Canada will begin selling CapsoVision's CapsoCam Plus system in Canada.
Gemelli Biotech's ibs-smart blood test for IBS patients is now commercially available.
Motus GI presented research demonstrating the effectiveness of its Pure-Vu System at the ACG 2018 Annual Meeting, held Oct. 5 through Oct. 10 in Philadelphia.